Cargando…
Anti-hepatitis C virus drugs and kidney
Hepatitis C virus (HCV) mainly targets the liver but can also induce extrahepatic manifestations. The kidney may be impacted via an immune mediated mechanism or a cytopathic effect. HCV patients are clearly at a greater risk of chronic kidney disease (CKD) than uninfected patients are, and the prese...
Autores principales: | Carrier, Paul, Essig, Marie, Debette-Gratien, Marilyne, Sautereau, Denis, Rousseau, Annick, Marquet, Pierre, Jacques, Jérémie, Loustaud-Ratti, Véronique |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5114471/ https://www.ncbi.nlm.nih.gov/pubmed/27917261 http://dx.doi.org/10.4254/wjh.v8.i32.1343 |
Ejemplares similares
-
European Association for the Study of the Liver and French hepatitis C recent guidelines: The paradigm shift
por: Loustaud-Ratti, Véronique, et al.
Publicado: (2018) -
Cirrhotic patients and older people
por: Carrier, Paul, et al.
Publicado: (2019) -
Liver Illness and Psychiatric Patients
por: Carrier, Paul, et al.
Publicado: (2016) -
Iohexol plasma and urinary concentrations in cirrhotic patients: A pilot study
por: Carrier, Paul, et al.
Publicado: (2022) -
Alpha‐fetoprotein and focal nodular hyperplasia: An unconventional couple
por: Carrier, Paul, et al.
Publicado: (2021)